Latest Hoffmann-La Roche Stories
NUTLEY, N.J., May 23, 2011 /PRNewswire/ -- Today, Roche honored 12 outstanding PhD students and two professors with the company's Excellence in Chemistry Award for research accomplishments in the field of organic chemistry. The winners are participating in Roche's annual two-day Roche Symposium: Excellence in Chemistry to gain first hand knowledge on the important role organic chemistry plays in pharmaceutical discovery. "These students come from a broad range of universities and...
NUTLEY, N.J., May 5, 2011 /PRNewswire/ -- Susan Graf, of Nutley, N.J., Global Head of Strategic Evaluation and Due Diligence in Roche Partnering, was honored as a 2011 Rising Star by the Healthcare Businesswomen's Association (HBA) at the organization's annual awards luncheon today in New York City. "I have had the pleasure of working with Susan on a number of projects over the past few years. We are all extremely proud of her and fully aware of the many contributions she has made to the...
SOUTHBOROUGH, Mass., April 25, 2011 /PRNewswire/ -- SynapDx Corporation announced today that Thomas Mac Mahon has joined its board of directors. Thomas Mac Mahon was President and Chief Executive Officer and a member of the Executive and Management Committees of Laboratory Corporation of America (LabCorp) from January 1997 until his retirement at the end of 2006. Prior to LabCorp, Mr. Mac Mahon was Senior Vice President of Hoffmann-La Roche Inc. (Roche) from 1993 to December 1996 and...
PARSIPPANY, N.J., April 14, 2011 /PRNewswire/ -- GlaxoSmithKline (GSK) is committed to ensuring that consumers and physicians understand the safety profile of orlistat and alli. alli is safe and effective when used as directed. Orlistat is minimally absorbed in the blood and works locally in the gastro-intestinal tract. GSK continues to proactively monitor for the safety of orlistat and share all relevant information with regulatory agencies. Since orlistat first became available as a...
INDIANAPOLIS, April 6, 2011 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the David H. Koch Institute for Integrative Cancer Research at MIT will be using the Roche LightCycler® 480 System, a real-time polymerase chain reaction (PCR) system for the analysis of gene expression and genetic variation, in advanced cancer research. The Koch Institute plans to use the LightCycler 480 System to support several key areas of research it has identified as being critical...
INDIANAPOLIS and FORT BRAGG, N.C., Feb. 23, 2011 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has received approval from the U.S. Department of Defense (DOD) to provide remote service and support for its lab analyzers at Womack Army Medical Center through the DOD's secure B2B gateway. Roche is the first in-vitro (test tube) diagnostics manufacturer to be approved by the DOD for this remote access. The B2B gateway is a highly secure portal that enables external...
ROCHESTER, N.Y., Feb. 7, 2011 /PRNewswire/ -- Thermal Gradient, a Rochester, NY biotech company, announces a breakthrough in its fast PCR technology for molecular diagnostics. PCR (polymerase chain reaction) is the preferred critical step in virtually all forms of DNA testing. The company's latest generation of amplification devices has successfully developed and demonstrated the performance of PCR at speeds many times faster than conventional methods, achieving 8.5 decades of...
LONDON, February 7, 2011 /PRNewswire/ -- GlaxoSmithKline (GSK) today announces that it has received a licence extension for alli, the first pharmacy-only weight loss aid licensed for use throughout Europe. This license extension is for new chewable tablets. The new alli tablets are planned to be on sale in pharmacies throughout the UK in April this year. alli is for overweight adults with a BMI of 28 or more and can help boost your weight loss compared with dieting alone. alli...
CHICAGO, Feb. 4, 2011 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Roche Holdings Ltd. (RHHBY), Eli Lilly & Co. (LLY), Bristol-Myers Squibb Co. (BMY), Genzyme Corp. (GENZ) and GlaxoSmithKline plc (GSK). (Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO) Get the most...
PLEASANTON, Calif., Feb. 4, 2011 /PRNewswire/ -- Roche (SIX: RO, ROG; Pink Sheets: RHHBY) announced today that the cobas® TaqScreen DPX Test for use on the cobas s 201 system is now available in the US. It is the first commercial test to quantify parvovirus B19 and detect hepatitis A virus (HAV) simultaneously in one assay in human plasma. Human plasma is used to create treatments for life-threatening and chronic diseases and disorders such as hemophilia and primary immunodeficiency...
